Antioxidant vitamin status of obese patients in terms of the risk of comorbidities
https://doi.org/10.14341/omet10144
Abstract
BACKGROUND: Synchronously optimized concentrations of vitamins C, E, A, carotenoids and their ratios in blood plasma help to prevent or slow down the development of many alimentary-dependent diseases and their complications.
AIMS: to characterize the vitamin status of obese patients from the standpoint of the risk of progression of existing and development of associated diseases.
MATERIALS AND METHODS: An observational single-site cross-sectional study of the sufficiency with antioxidant vitamins in 81 patients (21 men, 60 women) aged 20–75 years with body mass index 40,7±1,2 kg/m2, enrolled for treatment from April to June in Federal Research Centre of Nutrition, Biotechnology had been conducted. The concentration of α- and γ-tocopherols, retinol, ascorbic acid, β-carotene was determined in blood serum and their ratios with lipid profile were calculated.
RESULTS: Indicators of vitamin status were determined in 35 patients with obesity, 27 patients with obesity and cardiovascular diseases (CVD), 19 patients with obesity and type 2 diabetes mellitus (T2DM). The concentration of ascorbic acid in more than 50% of patients did not reach the optimal level (50 µmol/l). Compared to patients of other groups, patients with T2DM were better supplied with vitamin E, but worse with other vitamins. They have a non-optimal ratio of concentrations of vitamin C and E more often compared with patients of other groups (p≤0.050). Among them, the combined suboptimal level of vitamin C and β-carotene (<0.4 µmol/l) was detected 1.6–1.8 fold more often. The lack of antioxidants in patients with T2DM according to simultaneously reduced vitamin C/vitamin E ratio (<1.5) and β-carotene level was detected 3.3-fold more often, synchronously lowered vitamin C/vitamin E ratio and vitamin C level – 2.4-fold. γ-tocopherol level in serum of patients with T2DM tended to increase compared with that in patients with obesity (p=0.063) and CVD (p=0.081), γ-tocopherol/triacylglycerides ratio was 1.5-fold higher (respectively р=0.009 и р=0.076). Only in 2 patients with obesity and 2 patients with CVD all serum indicators corresponded to the optimal level of all vitamins. In terms of α-tocopherol/cholesterol (<5 µmol/mol), an increased risk of myocardial infarction was detected in 10.5–42.9% of the examined patients. Glucose level was positively associated with serum levels of α- and γ-tocopherols, as well as cholesterol-adjusted individual tocopherols; while glycemia was inversely associated with triacylglycerides-standardized individual tocopherols, as well as β-carotene and vitamin C/vitamin E ratio.
CONCLUSIONS: In most patients, a non-optimal serum vitamin content was found according to one or several parameters. In order to vitamin C/vitamin E ratio, patients with T2DM need to increase vitamin C intake. Increasing serum β-carotene and achieving an optimal C/E ratio will help to prevent an increase in glycemia.
About the Authors
Vera M. KodentsovaRussian Federation
BD, PhD in biology, Professor
Oksana A. Vrzhesinskaya
Russian Federation
PhD in biology
Olga V. Kosheleva
Russian Federation
Researcher, Laboratory of Vitamins and Minerals
Nina А. Beketova
Russian Federation
PhD in chemistry
Khaider Kh. Sharafetdinov
Russian Federation
MD, PhD
References
1. Дедов И.И., Мельниченко Г.А., Шестакова М.В., и др. Национальные клинические рекомендации по лечению морбидного ожирения у взрослых. 3-й пересмотр (лечение морбидного ожирения у взрослых) // Ожирение и метаболизм. — 2018. — Т. 15. — № 1. — С. 53-70. [Dedov II, Melnichenko GA, Shestakova MV, et al. Russian national clinical recommendations for morbid obesity treatment in adults. 3rd revision (Morbid obesity treatment in adults). Obesity and metabolism. 2018;15(1):53-70. (In Russ.)] DOI:10.14341/omet2018153-70
2. Bischoff-Ferrari H. Vitamin D - from essentiality to functionality. Int J Vitam Nutr Res. 2012;82(5):321-326. DOI:10.1024/0300-9831/a000126
3. Коденцова В.М. Современные тенденции в витаминологии // Вопросы питания. — 2018. — Т. 87. — № S5. — С. 59-60. [Kodentsova VM. Sovremennye tendentsii v vitaminologii. Problems of nutrition. 2018;87(S5):59-60. (In Russ.)] DOI:10.24411/0042-8833-2018-10145
4. Shahidi F, de Camargo AC. Tocopherols and Tocotrienols in Common and Emerging Dietary Sources: Occurrence, Applications, and Health Benefits. Int J Mol Sci. 2016;17(10). DOI:10.3390/ijms17101745
5. Gast GC, de Roos NM, Sluijs I, et al. A high menaquinone intake reduces the incidence of coronary heart disease. Nutr Metab Cardiovasc Dis. 2009;19(7):504-510. DOI:10.1016/j.numecd.2008.10.004
6. Дедов И.И., Мельниченко Г.А., Пигарова Е.А., и др. Дефицит витамина D у взрослых: диагностика, лечение и профилактика. Клинические рекомендации. — М.: Российская ассоциация эндокринологов; 2015. [Dedov II, Mel’nichenko GA, Pigarova EA, et al. Defitsit vitamina D u vzroslykh: diagnostika, lechenie i profilaktika. Klinicheskie rekomendatsii. Moscow: Rossiyskaya assotsiatsiya endokrinologov; 2015. (In Russ.)]
7. Hossein-nezhad A, Holick MF. Vitamin D for health: a global perspective. Mayo Clin Proc. 2013;88(7):720-755. DOI:10.1016/j.mayocp.2013.05.011
8. Mathur P, Ding Z, Saldeen T, Mehta JL. Tocopherols in the Prevention and Treatment of Atherosclerosis and Related Cardiovascular Disease. Clin Cardiol. 2015;38(9):570-576. DOI:10.1002/clc.22422
9. Cook-Mills J, Gebretsadik T, Abdala-Valencia H, et al. Interaction of vitamin E isoforms on asthma and allergic airway disease. Thorax. 2016;71(10):954-956. DOI:10.1136/thoraxjnl-2016-208494
10. McCary CA, Abdala-Valencia H, Berdnikovs S, Cook-Mills JM. Supplemental and highly elevated tocopherol doses differentially regulate allergic inflammation: reversibility of alpha-tocopherol and gamma-tocopherol’s effects. J Immunol. 2011;186(6):3674-3685. DOI:10.4049/jimmunol.1003037
11. Waniek S, di Giuseppe R, Plachta-Danielzik S, et al. Association of Vitamin E Levels with Metabolic Syndrome, and MRI-Derived Body Fat Volumes and Liver Fat Content. Nutrients. 2017;9(10). DOI:10.3390/nu9101143
12. Miranda C, Duarte VHR, Cruz MSM, et al. Association of Serum Alpha-Tocopherol and Retinol with the Extent of Coronary Lesions in Coronary Artery Disease. J Nutr Metab. 2018;2018:6104169. DOI:10.1155/2018/6104169
13. Cangemi R, Pignatelli P, Carnevale R, et al. Cholesterol-adjusted vitamin E serum levels are associated with cardiovascular events in patients with non-valvular atrial fibrillation. Int J Cardiol. 2013;168(4):3241-3247. DOI:10.1016/j.ijcard.2013.04.142
14. Mebazaa A, Mechmeche R, Alcindor LGr, et al. Vitamin E and Coronary Heart Disease in Tunisians. Clin Chem. 2000;46(9):1401-1405. DOI:10.1093/clinchem/46.9.1401
15. Gey KF. Vitamins E plus C and interacting conutrients required for optimal health. A critical and constructive review of epidemiology and supplementation data regarding cardiovascular disease and cancer. Biofactors. 1998;7(1-2):113-174. DOI:10.1002/biof.5520070115
16. Traber MG. Mechanisms for the prevention of vitamin E excess. J Lipid Res. 2013;54(9):2295-2306. DOI:10.1194/jlr.R032946
17. Бекетова Н.А., Дербенева С.А., Спиричев В.Б., и др. Обеспеченность антиоксидантами и показатели липидного спектра крови пациентов с сердечно-сосудистой патологией // Вопросы питания. — 2007. — Т. 76. — №3. — С. 11-18. [Beketova NA, Derbeneva SA, Spirichev VB, et al. Serum levels of antioxidants and lipid metabolism in patients with cardiovascular disease. Problems of nutrition. 2007;76(3):11-18. (In Russ.)]
18. Ellulu MS. Obesity, cardiovascular disease, and role of vitamin C on inflammation: a review of facts and underlying mechanisms. Inflammopharmacology. 2017;25(3):313-328. DOI:10.1007/s10787-017-0314-7
19. Peter S, Friedel A, Roos FF, et al. A Systematic Review of Global Alpha-Tocopherol Status as Assessed by Nutritional Intake Levels and Blood Serum Concentrations. Int J Vitam Nutr Res. 2015;85(5-6):261-281. DOI:10.1024/0300-9831/a000281
20. Якушина Л.М., Бекетова Н.А., Бендер Е.Д., Харитончик Л.А. Использование методов ВЭЖХ для определения витаминов в биологических жидкостях и пищевых продуктах // Вопросы питания. — 1993. — №1. — С. 43-48. [Yakushina LM, Beketova NA, Bender ED, Kharitonchik LA. Ispol’zovanie metodov VEZhKh dlya opredeleniya vitaminov v biologicheskikh zhidkostyakh i pishchevykh produktakh. Problems of nutrition 1993;(1):43-48. (In Russ.)]
21. Thurnham DI, Davies JA, Crump BJ, et al. The use of different lipids to express serum tocopherol: lipid ratios for the measurement of vitamin E status. Ann Clin Biochem. 1986;23(Pt 5):514-520. DOI:10.1177/000456328602300505
22. Waniek S, di Giuseppe R, Esatbeyoglu T, et al. Vitamin E (alpha- and gamma-Tocopherol) Levels in the Community: Distribution, Clinical and Biochemical Correlates, and Association with Dietary Patterns. Nutrients. 2017;10(1). DOI:10.3390/nu10010003
Supplementary files
|
1. Figure 1. The number of patients with indicators that do not reach optimal values. | |
Subject | ||
Type | Other | |
View
(218KB)
|
Indexing metadata ▾ |
![]() |
2. Рисунок 1 Word | |
Subject | ||
Type | Исследовательские инструменты | |
Download
(30KB)
|
Indexing metadata ▾ |
|
3. Figure 2. The relative number of individuals with indicators of the provision of vitamins corresponding to the optimal level, and suboptimal provision for several indicators | |
Subject | ||
Type | Other | |
View
(202KB)
|
Indexing metadata ▾ |
![]() |
4. Рисунок 2 Word | |
Subject | ||
Type | Исследовательские инструменты | |
Download
(28KB)
|
Indexing metadata ▾ |
Review
For citations:
Kodentsova V.M., Vrzhesinskaya O.A., Kosheleva O.V., Beketova N.А., Sharafetdinov Kh.Kh. Antioxidant vitamin status of obese patients in terms of the risk of comorbidities. Obesity and metabolism. 2020;17(1):22-32. (In Russ.) https://doi.org/10.14341/omet10144

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).